Current role
Andrew J. Murphy
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew J. Murphy
The proxy statement of Regeneron Pharmaceuticals, Inc. reports total compensation of $8,477,119 for Andrew J. Murphy in fiscal 2025, including a base salary of $819,672. Disclosed compensation is on record for 7 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Regeneron Pharmaceuticals, Inc. (REGN)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Regeneron Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- George D. Yancopoulos, M.D., Ph.D. Chairman
- Leonard S. Schleifer, M.D., Ph.D. Chairman
- Joseph J. LaRosa General Counsel
- Christine A. Poon Board Member
- Craig B. Thompson, M.D. Board Member
- David P. Schenkein Board Member
- David P. Schenkein, M.D. Board Member
- Huda Y. Zoghbi, M.D. Board Member
- Joseph L. Goldstein, M.D. Board Member
- Kathryn Guarini Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Co-Chief Scientific Officer | $819,672 | $8,477,119 |
| 2024 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer | $803,600 | $8,363,257 |
| 2023 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer | $776,250 | $8,429,311 |
| 2022 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer | $750,000 | $9,122,529 |
| 2021 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $724,500 | $7,146,830 |
| 2020 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $726,923 | $10,998,914 |
| 2019 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $600,000 | $9,519,347 |
Recent activity
No call appearances or filed executive changes recorded yet.